Join to View Full Profile
10201 Grosvenor PlApt 901Rockville, MD 20852
Phone+1 240-423-7348
Dr. Perl is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 2005 - 2008
Ben Gurion University of the NegevClass of 1999
Certifications & Licensure
MD State Medical License 2007 - 2027
Clinical Trials
- Screening Protocol for Subjects Being Evaluated for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Protocols Start of enrollment: 2009 Aug 06
- Effects of Rosuvastatin on the Immune System in Healthy Volunteers With Normal Cholesterol Start of enrollment: 2010 Jul 01
Publications & Presentations
PubMed
- Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant Hypertension.John M Flack, Michel Azizi, Jenifer M Brown, Jamie P Dwyer, Jakub Fronczek
The New England Journal of Medicine. 2025-10-09 - 1 citationsBaxdrostat for uncontrolled and resistant hypertension: rationale and design of the Phase 3 clinical trials BaxHTN, BaxAsia, and Bax24.John M Flack, Michel Azizi, Jenifer M Brown, Jamie P Dwyer, Erika S W Jones
Hypertension Research. 2025-08-25 - 4 citationsVerinurad Plus Allopurinol for Heart Failure With Preserved Ejection Fraction: The AMETHYST Randomized Clinical Trial.Dalane W Kitzman, Adriaan A Voors, Robert J Mentz, Gregory D Lewis, Shira Perl
JAMA Cardiology. 2024-10-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
